# Aureka Biotechnologies raises USD 35 million in Series A+ financing

On 2026-04-28, according to Xiniu Data, Aureka Biotechnologies completed Series A+ financing, raising USD 35 million. Investors were lead investor Hongshan China, Jingwei Venture Capital, Boyuan Capital, Wuyuan Capital and others. The company is a developer of antibody drugs using generative AI.



Canonical: https://uniquebase.ai/news/f6faa94b-ac7b-488d-9432-df41acc518b5
Stable identifier: f6faa94b-ac7b-488d-9432-df41acc518b5
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:23:00.946Z

## Connected profiles

- [Aureka Biotechnologies](/companies/aureka-biotechnologies)
- [Boyuan Capital](/institutions/UB-I2854)
- [Hongshan China](/institutions/hongshan-china)
- [Jingwei Venture Capital](/institutions/jingwei-venture-capital)
- [Niuerli Capital](/institutions/niuerli-capital)
- [Qiming Venture Capital](/institutions/qiming-venture-capital)
- [Wuyuan Capital](/institutions/wuyuan-capital)

## Sources

- No source links are available for this profile.